Cargando…
Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits
BACKGROUND: Although technological advances now allow increased tumor profiling, a detailed understanding of the mechanisms leading to the development of different cancers remains elusive. Our approach toward understanding the molecular events that lead to cancer is to characterize changes in transc...
Autores principales: | Rhie, Suhn Kyong, Guo, Yu, Tak, Yu Gyoung, Yao, Lijing, Shen, Hui, Coetzee, Gerhard A., Laird, Peter W., Farnham, Peggy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103450/ https://www.ncbi.nlm.nih.gov/pubmed/27833659 http://dx.doi.org/10.1186/s13072-016-0102-4 |
Ejemplares similares
-
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops
por: Guo, Yu, et al.
Publicado: (2018) -
TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma
por: Mullen, Daniel J., et al.
Publicado: (2020) -
A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome
por: Rhie, Suhn Kyong, et al.
Publicado: (2019) -
The Enigmatic HOX Genes: Can We Crack Their Code?
por: Luo, Zhifei, et al.
Publicado: (2019) -
Demystifying the secret mission of enhancers: linking distal regulatory elements to target genes
por: Yao, Lijing, et al.
Publicado: (2015)